Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trial

Clemens von Birgelen, Hanim Sen, Ming Kai Lam, Peter W. Danse, Gillian A.J. Jessurun, Raymond W.M. Hautvast, Gert K. van Houwelingen, Alexander R. Schramm, R. Melvyn Tjon Joe Gin, Johannes W. Louwerenburg, Frits H.A.F. de Man, Martin G. Stoel, Marije M. Löwik, Gerard C.M. Linssen, Salah A.M. Saïd, Mark B. Nienhuis, Patrick M.J. Verhorst, Mounir W.Z. Basalus, Catharina J.M. Doggen, Kenneth Tandjung

Research output: Contribution to journalArticleAcademicpeer-review

166 Citations (Scopus)
19 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trial'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science